OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 184 filers reported holding OPHTHOTECH CORP in Q2 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,000 | -79.2% | 2,037 | +96.4% | 0.00% | -100.0% |
| Q3 2016 | $48,000 | -9.4% | 1,037 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $53,000 | +20.5% | 1,037 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $44,000 | -45.7% | 1,037 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $81,000 | +8000.0% | 1,037 | +2702.7% | 0.00% | – |
| Q3 2015 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JHL Capital Group LLC | 3,265,000 | $166,613,000 | 20.59% |
| Novo Holdings A/S | 3,610,487 | $184,243,000 | 19.34% |
| Green Owl Capital Management, LLC | 847 | $834,000 | 5.16% |
| Ghost Tree Capital, LLC | 215,000 | $10,971,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $822,000 | 2.76% |
| IMA Wealth, Inc. | 57,131 | $2,867,000 | 1.80% |
| Slate Path Capital LP | 430,000 | $21,943,000 | 1.72% |
| Signpost Capital Advisors, LP | 50,587 | $2,581,000 | 1.36% |
| Orbimed Advisors | 2,148,100 | $109,618,000 | 1.14% |
| PURA VIDA INVESTMENTS, LLC | 52,500 | $2,679,000 | 1.14% |